Radical Imaging Receives FDA Clearance for FlexView Diagnostic, its SaaS Image Viewer for Diagnostic Use

Tuesday, June 25, 2024

Radical Imaging is excited to announce FDA clearance for its SaaS web DICOM viewer, FlexView Diagnostic, a groundbreaking advancement in medical imaging solutions. This enables clinicians and radiologists to utilize a powerful, fast, and intuitive tool for diagnostic imaging tasks, eliminating the need for software installation.

Key Features of FlexView Diagnostic:

  • User-friendly Interface: Designed to be intuitive yet powerful enough for diagnostic radiology and clinical subspecialty imaging, requiring minimal training.

  • Speed: Rapid loading of cloud-based images, capable of handling large imaging studies efficiently.

  • Advanced Imaging Capabilities: Includes seamless 3D rendering, multi-modality fusion, and segmentation tools, enhancing diagnostic accuracy.

  • Integration-Ready: Easily integrates into existing platforms, offering a streamlined image viewing experience without lengthy setup times.

"Thrilled that our collaboration with MGH Department of Radiology has led to the recognition of the OHIF open-source viewer within the medical imaging community. With FlexView Diagnostic, we extend this exceptional user experience to those requiring an FDA cleared class II medical device for diagnostic work.

Cloud-native viewer ensures security, scalability, and ease of integration, supported by rigorous quality processes and expert technical assistance, aiming to redefine the diagnostic imaging experience."






Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital Congress